Compare NBHC & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBHC | INSP |
|---|---|---|
| Founded | 2009 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 2011 | 2018 |
| Metric | NBHC | INSP |
|---|---|---|
| Price | $41.25 | $65.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 16 |
| Target Price | $47.67 | ★ $94.00 |
| AVG Volume (30 Days) | 298.8K | ★ 393.0K |
| Earning Date | 04-21-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.03% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ 1.04 | N/A |
| Revenue | $47,100,000.00 | ★ $82,050,000.00 |
| Revenue This Year | $39.96 | $8.02 |
| Revenue Next Year | $7.14 | $8.11 |
| P/E Ratio | $40.16 | ★ N/A |
| Revenue Growth | 2.86 | ★ 62.18 |
| 52 Week Low | $35.06 | $38.91 |
| 52 Week High | $47.28 | $147.03 |
| Indicator | NBHC | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 39.49 | 66.63 |
| Support Level | $40.47 | $56.50 |
| Resistance Level | $42.74 | $66.21 |
| Average True Range (ATR) | 0.61 | 2.75 |
| MACD | 0.06 | -0.05 |
| Stochastic Oscillator | 43.48 | 80.27 |
National Bank Holdings Corp offers a full range of banking products and financial services to commercial, business, and consumer clients predominantly in Colorado, with a focus on personalized service through relationship managers and banking center associates. The company provides commercial and industrial loans, non-owner occupied commercial real estate loans, Small Business Administration loans as a Preferred Lender Provider, U.S. Department of Agriculture and Farm Service Agency loans, commercial deposit and treasury management products, business online and mobile banking, consumer and residential real estate loans, deposit services, and trust and wealth management services. Its services emphasize full-relationship banking, integrating lending, deposits, and cash management solutions.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.